# CDR-Life Inc.: Research, Horgen, Switzerland

> CDR-Life Inc.: CDR-Life Inc. is a Swiss biotherapeutics company founded in 2017 and based in Schlieren, Zurich. Based in Horgen, Switzerland. Founded 2017.

Source: https://millionrounds.com/startup/cdr-life-inc (Millionrounds; every figure on the page links to its filing or article)

Switzerland · [Research startup](https://millionrounds.com/companies)

# CDR-Life Inc.

CDR-Life Inc. is a Swiss biotherapeutics company founded in 2017 and based in Schlieren, Zurich.

Funding reported Last round: Series A

Research Horgen, Switzerland

Company summary

- **Founded:** 2017 9 years old
- **Team:** 73 51 to 200 people
- **Funding reported:** 76M as listed, currency not stated
- **Last round:** Series A Apr 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for CDR-Life Inc. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About CDR-Life Inc.

CDR-Life Inc. is a Swiss biotherapeutics company founded in 2017 and based in Schlieren, Zurich.

The company focuses on developing next-generation immunotherapies for cancer and autoimmune diseases. Led by CEO Christian Leisner and co-founders Dominik Escher and Konstantin von Schulthess, CDR-Life aims to create therapies that precisely target tumor cells while minimizing effects on healthy tissue. The company's core technology, the M-gager® platform, enables the development of highly selective T-cell engagers that target intracellular tumor antigens. This innovative approach allows for the creation of first-in-class immunotherapies for both solid tumors, such as lung and breast cancer, and liquid tumors like multiple myeloma. CDR-Life is currently advancing several investigational drug candidates, with two already in human testing. The company has also established strategic collaborations, including a partnership with Boehringer Ingelheim for an antibody fragment therapy targeting macular degeneration.

## What company datasets say CDR-Life Inc. raised

Funding, as reported

Reported in all **76M** in the source's currency

Rounds **1**

Last round **Series A**

Last round size **76M**

Last round date **Apr 2022**

Investors listed **3**

## Founders and team

From CDR-Life Inc.'s own website: 5 founders, 7 on the team.

**Christian Leisner** Chief Executive Officer & Co-founder

**Konstantin von Schulthess** Chief Financial Officer & Co-founder

**Leonardo Borras** Chief Scientific Officer & Co-founder

**Rouven Bingel-Erlenmeyer** Chief Technology Officer & Co-founder

**Dr. Dominik Escher** Chairman & Co-founder

- **Dimitrios Chondros** Chief Medical Officer
- **Sarah Holland** Chief Business Officer
- **Betty Chen** Research Operation Manager
- **Dr. Claudio Nessi** Director
- **Dr. Mehdi Ainouche** Director
- **Dr. Nicole Onetto** Director
- **Fanny Cavalié** Director

## On a portfolio page

Investors who name them

- [Jeito Capital](https://millionrounds.com/fund/jeito-capital)

Each firm lists CDR-Life Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care antibody humanization biotechnology research bispecific tces antigen-specific t cell activation mhc targeting medical research immune system activation bispecific antibodies autoimmune cell targeting indication-specific therapies hospital & health care antibody stability target-specific therapy autoimmune treatment cancer immunotherapy

Built with from their website

Yoast SEO Google Maps Contact Form 7 Google Tag Manager WordPress.org PWA Font Awesome Apache Viewport Meta Yoast

+8 more

Google Analytics Cloudflare Rocket Loader Google Analytics 4 Wordpress Microsoft Exchange Online jQuery Migrate Google Maps Platform Priority Hints

- **Sector:** Research
- **Industry code:** NAICS 541714, 325414, SIC 2834, 2836
- **Region:** Zurich
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/cdr-life-ag)

## Research in Switzerland

Startups like it

- [**Nouscom** Basel · founded 2015 *Raised*](https://millionrounds.com/company/nouscom)
- [**Hedera Dx** Epalinges · founded 2021 *Raised*](https://millionrounds.com/company/hedera-dx)
- [**Bio Protocol** Zug *Raised*](https://millionrounds.com/company/bio-protocol)
- [**InVirtuoLabs** Lugano · founded 2024 *Raised*](https://millionrounds.com/company/invirtuolabs)
- [**NEMIS Technologies** Waedenswil · founded 2018 *Raised*](https://millionrounds.com/company/nemis-technologies)
- [**Windward Bio** Basel](https://millionrounds.com/startup/windward-bio)
- [**Bright Peak Therapeutics** Basel · founded 2017](https://millionrounds.com/startup/bright-peak-therapeutics)
- [**Numab Therapeutics AG** Horgen · founded 2011](https://millionrounds.com/startup/numab-therapeutics-ag)

## Is this your company?

Add your raise, your deck and your story, and put CDR-Life Inc. in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)